David Nutt

3.5k total citations
72 papers, 2.5k citations indexed

About

David Nutt is a scholar working on Cellular and Molecular Neuroscience, Cognitive Neuroscience and Molecular Biology. According to data from OpenAlex, David Nutt has authored 72 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Cellular and Molecular Neuroscience, 22 papers in Cognitive Neuroscience and 19 papers in Molecular Biology. Recurrent topics in David Nutt's work include Neurotransmitter Receptor Influence on Behavior (53 papers), Neuroscience and Neuropharmacology Research (15 papers) and Receptor Mechanisms and Signaling (12 papers). David Nutt is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (53 papers), Neuroscience and Neuropharmacology Research (15 papers) and Receptor Mechanisms and Signaling (12 papers). David Nutt collaborates with scholars based in United Kingdom, United States and Netherlands. David Nutt's co-authors include Alan L. Hudson, Anne Lingford‐Hughes, Paul Glue, David A. Slattery, Trevor W. Robbins, Lisa A. Lione, Richard M. Eglen, Michael P. Dillon, Noel G. Morgan and David A. Kendall and has published in prestigious journals such as Nature, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

David Nutt

68 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Nutt United Kingdom 29 1.3k 758 480 387 348 72 2.5k
Becky Kinkead United States 28 953 0.7× 826 1.1× 376 0.8× 302 0.8× 329 0.9× 64 2.6k
Andrew J. Goudie United Kingdom 31 1.7k 1.3× 633 0.8× 652 1.4× 355 0.9× 279 0.8× 94 3.2k
Yves Chaput Canada 20 1.6k 1.2× 858 1.1× 404 0.8× 178 0.5× 497 1.4× 31 2.3k
Marco Catalano Italy 25 1.3k 1.0× 647 0.9× 394 0.8× 290 0.7× 387 1.1× 49 2.8k
Terry Ritchie United States 27 1.3k 1.0× 787 1.0× 415 0.9× 267 0.7× 252 0.7× 46 2.8k
G. Laakmann Germany 25 774 0.6× 478 0.6× 466 1.0× 440 1.1× 538 1.5× 81 2.7k
Gary B. Kaplan United States 30 943 0.7× 559 0.7× 408 0.8× 259 0.7× 452 1.3× 65 2.3k
Richard De La Garza United States 39 2.0k 1.5× 777 1.0× 677 1.4× 343 0.9× 807 2.3× 143 4.1k
Richard M. Mangano United States 21 813 0.6× 521 0.7× 576 1.2× 786 2.0× 209 0.6× 35 2.4k
Robert H. Ring United States 24 870 0.7× 653 0.9× 766 1.6× 199 0.5× 355 1.0× 35 2.7k

Countries citing papers authored by David Nutt

Since Specialization
Citations

This map shows the geographic impact of David Nutt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Nutt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Nutt more than expected).

Fields of papers citing papers by David Nutt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Nutt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Nutt. The network helps show where David Nutt may publish in the future.

Co-authorship network of co-authors of David Nutt

This figure shows the co-authorship network connecting the top 25 collaborators of David Nutt. A scholar is included among the top collaborators of David Nutt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Nutt. David Nutt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wall, Matthew B., Rebecca Harding, Rayyan Zafar, et al.. (2024). Neuroimaging and the Investigation of Drug-Drug Interactions Involving Psychedelics. SHILAP Revista de lepidopterología. 19. 2318914422–2318914422.
3.
Nutt, David & Liam J. Nestor. (2018). Addiction (Oxford Psychiatry Library). Oxford University Press eBooks.
4.
Brink, Wim van den, Giovanni Addolorato, Henri‐Jean Aubin, et al.. (2018). Efficacy and safety of sodium oxybate in alcohol‐dependent patients with a very high drinking risk level. Addiction Biology. 23(4). 969–986. 44 indexed citations
5.
Nestor, Liam J., Anna Murphy, John McGonigle, et al.. (2016). Acute naltrexone does not remediate fronto‐striatal disturbances in alcoholic and alcoholic polysubstance‐dependent populations during a monetary incentive delay task. Addiction Biology. 22(6). 1576–1589. 29 indexed citations
6.
Nutt, David, Stephen M. Stahl, Pierre Blier, et al.. (2016). Inverse agonists – What do they mean for psychiatry?. European Neuropsychopharmacology. 27(1). 87–90. 14 indexed citations
7.
Taylor, Eleanor, Anna Murphy, Karen D. Ersche, et al.. (2016). Impulsivity in abstinent alcohol and polydrug dependence: a multidimensional approach. Psychopharmacology. 233(8). 1487–1499. 23 indexed citations
8.
Insel, Thomas R., Valerie Voon, Jeffrey S. Nye, et al.. (2013). Innovative solutions to novel drug development in mental health. Neuroscience & Biobehavioral Reviews. 37(10). 2438–2444. 75 indexed citations
9.
Nutt, David, Anne Lingford‐Hughes, & Mark Daglish. (2003). Future directions in substance dependence research. Journal of neural transmission. Supplementum. 95–103. 8 indexed citations
10.
Finn, David P., Octavi Martı́, Michael S. Harbuz, et al.. (2003). Behavioral, neuroendocrine and neurochemical effects of the imidazoline I2 receptor selective ligand BU224 in naive rats and rats exposed to the stress of the forced swim test. Psychopharmacology. 167(2). 195–202. 44 indexed citations
11.
Weinstein, Aviv, et al.. (2001). Effects of contextual priming of reactions to craving and withdrawal stimuli in alcohol-dependent participants.. Experimental and Clinical Psychopharmacology. 9(3). 343–351. 8 indexed citations
12.
Nutt, David, Caroline Bell, & Andrea L. Malizia. (1998). Brain mechanisms of social anxiety disorder.. PubMed. 59 Suppl 17. 4–11. 63 indexed citations
13.
Eglen, Richard M., Alan L. Hudson, David A. Kendall, et al.. (1998). `Seeing through a glass darkly': casting light on imidazoline `I' sites. Trends in Pharmacological Sciences. 19(9). 381–390. 229 indexed citations
14.
Lione, Lisa A., David Nutt, & Alan L. Hudson. (1996). [3H]2-(2-Benzofuranyl)-2-imidazoline: a new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptors. European Journal of Pharmacology. 304(1-3). 221–229. 45 indexed citations
15.
Altman, Jennifer, Barry J. Everitt, Trevor W. Robbins, et al.. (1996). The biological, social and clinical bases of drug addiction: commentary and debate. Psychopharmacology. 125(4). 285–345. 212 indexed citations
16.
Nutt, David, Sheila L. Handley, Alan L. Hudson, et al.. (1995). Functional Studies of Specific Imidazoline‐2 Receptor Ligands. Annals of the New York Academy of Sciences. 763(1). 125–139. 97 indexed citations
17.
Coupland, Nicholas J., Jayne Bailey, Susan J. Wilson, William Z. Potter, & David Nutt. (1994). A pharmacodynamic study of the α2-adrenergic receptor antagonist ethoxyidazoxan in healthy volunteers. Clinical Pharmacology & Therapeutics. 56(4). 420–429. 11 indexed citations
18.
George, David T., Bryon Adinoff, David Nutt, et al.. (1990). A cerebrospinal fluid study of the pathophysiology of panic disorder associated with alcoholism. Acta Psychiatrica Scandinavica. 82(1). 1–7. 29 indexed citations
19.
Lister, Richard G., Michael J. Durcan, David Nutt, & Markku Linnoila. (1989). Attenuation of ethanol intoxication by alpha-2 adrenoceptor antagonists. Life Sciences. 44(2). 111–119. 31 indexed citations
20.
Nutt, David & Philip J. Cowen. (1987). Monoamine function in anxiety and depression: Information from neuroendocrine challenge tests. Human Psychopharmacology Clinical and Experimental. 2(4). 211–220. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Becky Kinkead Breakdown of academic impact, for papers by Andrew J. Goudie Breakdown of academic impact, for papers by Yves Chaput Breakdown of academic impact, for papers by Marco Catalano Breakdown of academic impact, for papers by Terry Ritchie Breakdown of academic impact, for papers by G. Laakmann Breakdown of academic impact, for papers by Gary B. Kaplan Breakdown of academic impact, for papers by Richard De La Garza Breakdown of academic impact, for papers by Richard M. Mangano Breakdown of academic impact, for papers by Robert H. Ring
Rankless by CCL
2026